Motivated by studies showing the connection between HER3 inhibition and inducing apoptosis in tumor cell lines (11, 32), we investigated whether the PAbs produced by the HER3-based vaccine candidate trigger markers of apoptosis in cells expressing EGFR family receptors. This evidence concerns the gene EGFR and neoplasm.